Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis

Tomasz Siwek; Katarzyna Jezierska-Woźniak; Stanisław Maksymowicz; Monika Barczewska; Mariusz Sowa; Wanda Badowska; Wojciech Maksymowicz

doi:10.12659/MSM.927484

10 December 2020 : Clinical Research

Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis

Tomasz Siwek^12ABDEFG*, Katarzyna Jezierska-Woźniak^3ABDEF, Stanisław Maksymowicz^4BCDEF, Monika Barczewska^56BD, Mariusz Sowa^57B, Wanda Badowska^8B, Wojciech Maksymowicz^57ADG

DOI: 10.12659/MSM.927484

Med Sci Monit 2020; 26:e927484

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 The monthly decrease in Revised Amyotrophic Lateral Sclerosis Functional Rating Scale scores before and after treatment for the participants with a slow rate of progression of amyotrophic lateral sclerosis (P=0028).

Back to the Article

Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis

Your Privacy